TherapeuticsMD (NASDAQ:TXMD) reported its Q4 earnings results on Thursday, March 10, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
TherapeuticsMD missed estimated earnings by 12.5%, reporting an EPS of $-0.09 versus an estimate of $-0.08.
Revenue was down $3.90 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01 which was followed by a 4.67% drop in the share price the next day.
Here's a look at TherapeuticsMD's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.10 | -0.11 | -0.12 | -0.10 |
| EPS Actual | -0.11 | -0.11 | -0.11 | -0.15 |
| Revenue Estimate | 25.87M | 22.11M | 19.77M | 21.89M |
| Revenue Actual | 25.41M | 23.00M | 19.87M | 22.58M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
